San Mateo, CA, United States of America

Donna Pruess Schwartz

This inventor holds 7 USPTO granted patents, plus 2 CIPO patents. Top assignees: Sugen Incorporated, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Baylor College of Medicine. Active years: 1997-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donna Pruess Schwartz. Retrieved from https://idiyas.com/inventor/donna-pruess-schwartz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 151(Granted Patents)


Company Filing History:


Years Active: 1997-2002

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Donna Pruess Schwartz: Innovator in Pharmaceutical Formulations

Introduction

Donna Pruess Schwartz is a notable inventor based in San Mateo, CA (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. Her work primarily focuses on innovative methods for treating various medical conditions through advanced formulations.

Latest Patents

One of her latest patents is titled "Method of treating a patient by parenteral administration of a lipophilic compound." This invention features pharmaceutical formulations that contain a lipophilic compound, such as leflunomide, which is solubilized in a solution containing alcohol and a surfactant. The solubilized compound can be further dissolved in a pharmaceutically acceptable aqueous solution, making it suitable for patient administration. This formulation is particularly designed for parenteral administration.

Another significant patent is related to the "Treatment of platelet derived growth factor related disorders." This invention concerns compounds that can inhibit platelet derived growth factor receptor (PDGF-R) activity. The compounds are designed to be selective for members of the PDGF-R super family, which includes PDGF-R and related kinases. The featured compounds have shown effectiveness in reducing the activity of PDGF-R in cell cultures and are intended for treating patients suffering from cell proliferative disorders characterized by inappropriate PDGF-R activity.

Career Highlights

Throughout her career, Donna has worked with prominent organizations, including Sugen Incorporated and the Max Planck Society for the Advancement of Science. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to advancements in treatment methodologies.

Collaborations

Donna has collaborated with notable professionals in her field, including Laura Kay Shawver and Klaus Peter Hirth. These collaborations have further enhanced her research and development efforts, leading to impactful innovations.

Conclusion

Donna Pruess Schwartz is a distinguished inventor whose work in pharmaceutical formulations has paved the way for new treatment options. Her contributions continue to influence the medical field, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…